+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Bone Wax Market By Product: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 280 Pages
  • July 2024
  • Region: Global
  • Allied Market Research
  • ID: 5994248
UP TO OFF until Oct 24th 2024
The bone wax market was valued at $53.1 million in 2023, and is projected to reach $73.0 million by 2033, growing at a CAGR of 3.2% from 2024 to 2033.

Bone wax is a mixture of beeswax, paraffin, and isopropyl palmitate, a wax-softening agent, used in surgical procedures to control bleeding from bone surfaces. Its pliable nature allows it to be easily molded and applied directly to the bone, effectively sealing bleeding points by mechanically blocking blood vessels. Bone wax is commonly used in orthopedic, neurosurgical, and cardiothoracic surgeries, particularly when working with the sternum or other bones prone to bleeding.

The growth of the global bone wax market is driven by rise in number of orthopedic, neurosurgical, and cardiovascular surgeries. According to a study published in 2020 by the National Institutes of Health - world's foremost medical research centers - approximately 310 million major surgeries are performed each year; around 40 to 50 million in the U.S. and 20 million in Europe. Furthermore, surge in geriatric population notably contributes toward the market growth. This is attributed to the fact that aged individuals are highly susceptible to conditions such as osteoporosis and other bone-related diseases, as minerals in bones of aged individuals start to leech out, making them brittle, fragile, and easily breakable, thereby necessitating the need for bone wax. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050. Furthermore, a significant trend is the development and adoption of biodegradable bone wax, which significantly boosts the market growth. Traditional bone wax, which is non-resorbable, has been associated with complications like impaired bone healing and infection. In response, manufacturers are introducing bioresorbable options that reduce these risks while still effectively controlling bleeding. However, concerns associated with traditional bone wax hamper the market growth. For instance, traditional bone wax is non-resorbable and can lead to complications such as impaired bone healing, foreign body reactions, and an increased risk of infection. Moreover, availability and preference for alternative hemostatic agents, such as fibrin sealants, gelatin sponges, and oxidized cellulose, which may offer better resorption and fewer complications, are restraining the growth of the bone wax market. On the contrary, innovations in surgical techniques and the development of more efficient and biocompatible bone wax formulations are offering lucrative opportunities for the market growth during the forecast period. Furthermore, with heightened awareness of surgical site infections, there is a growing trend toward bone wax products that incorporate antimicrobial properties. These advanced formulations aim to reduce the risk of post-operative infections, particularly in high-risk surgeries such as those involving the spine or cranium. Such developments are expected to open new avenues for the market growth in the coming years.

The global bone wax market is segmented into product, application, end user, and region. By product, the market is divided into absorbable bone wax and non-absorbable bone wax. On the basis of application, it is classified into orthopedic surgery, thoracic surgery, neurosurgery, and others. Depending on end user, it is categorized into specialty clinics, hospitals, and ambulatory surgery centers. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By product, the non-absorbable bone wax segment dominated the market, in terms of share, in 2023.

On the basis of application, the orthopedic segment was the major shareholder in 2023.

Depending on end user, hospital emerged as the leading segment in 2023.

Region wise, North America dominated the market share in 2023; however, Asia-Pacific is expected to register the highest CAGR during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global bone wax market include Zimmer Biomet Holdings, Inc., Medline Industries, Inc., Medtronic Plc, B Braun Melsungen AG, Baxter International, Inc, Johnson & Johnson, Dolphin Sutures, SMI AG, Orion Sutures India Pvt. Ltd., and Universal Suture These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to gain a strong foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Absorbable Bone Wax
  • Non-Absorbable Bone Wax

By Application

  • Orthopedic Surgery
  • Thoracic Surgery
  • Neurosurgery
  • Others

By End User

  • Specialty Clinics
  • Hospitals
  • Ambulatory Surgery Centers

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA
Key Market Players
  • Zimmer Biomet Holdings, Inc.
  • Medline Industries, Inc.
  • Medtronic plc
  • B Braun Melsungen AG
  • Baxter International, Inc
  • Johnson & Johnson
  • Dolphin Sutures
  • SMI AG
  • Orion Sutures India Pvt. Ltd
  • Universal Suture

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: BREAST CANCER SCREENING MARKET, BY TEST TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Test Type
4.2. Blood Marker Test
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Genetic Test
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Imaging Test
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Immunohistochemistry Test
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
CHAPTER 5: BREAST CANCER SCREENING MARKET, BY GENDER
5.1. Market Overview
5.1.1 Market Size and Forecast, By Gender
5.2. Male
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Female
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: BREAST CANCER SCREENING MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Specialty Clinics
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Hospitals
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Diagnostic Centers
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
6.5. Other
6.5.1. Key Market Trends, Growth Factors and Opportunities
6.5.2. Market Size and Forecast, By Region
6.5.3. Market Share Analysis, By Country
CHAPTER 7: BREAST CANCER SCREENING MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Test Type
7.2.3. Market Size and Forecast, By Gender
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Breast Cancer Screening Market
7.2.6.1. Market Size and Forecast, By Test Type
7.2.6.2. Market Size and Forecast, By Gender
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Breast Cancer Screening Market
7.2.7.1. Market Size and Forecast, By Test Type
7.2.7.2. Market Size and Forecast, By Gender
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Breast Cancer Screening Market
7.2.8.1. Market Size and Forecast, By Test Type
7.2.8.2. Market Size and Forecast, By Gender
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Test Type
7.3.3. Market Size and Forecast, By Gender
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Breast Cancer Screening Market
7.3.6.1. Market Size and Forecast, By Test Type
7.3.6.2. Market Size and Forecast, By Gender
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Breast Cancer Screening Market
7.3.7.1. Market Size and Forecast, By Test Type
7.3.7.2. Market Size and Forecast, By Gender
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Breast Cancer Screening Market
7.3.8.1. Market Size and Forecast, By Test Type
7.3.8.2. Market Size and Forecast, By Gender
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Breast Cancer Screening Market
7.3.9.1. Market Size and Forecast, By Test Type
7.3.9.2. Market Size and Forecast, By Gender
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Breast Cancer Screening Market
7.3.10.1. Market Size and Forecast, By Test Type
7.3.10.2. Market Size and Forecast, By Gender
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest of Europe Breast Cancer Screening Market
7.3.11.1. Market Size and Forecast, By Test Type
7.3.11.2. Market Size and Forecast, By Gender
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Test Type
7.4.3. Market Size and Forecast, By Gender
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Breast Cancer Screening Market
7.4.6.1. Market Size and Forecast, By Test Type
7.4.6.2. Market Size and Forecast, By Gender
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Breast Cancer Screening Market
7.4.7.1. Market Size and Forecast, By Test Type
7.4.7.2. Market Size and Forecast, By Gender
7.4.7.3. Market Size and Forecast, By End User
7.4.8. Australia Breast Cancer Screening Market
7.4.8.1. Market Size and Forecast, By Test Type
7.4.8.2. Market Size and Forecast, By Gender
7.4.8.3. Market Size and Forecast, By End User
7.4.9. India Breast Cancer Screening Market
7.4.9.1. Market Size and Forecast, By Test Type
7.4.9.2. Market Size and Forecast, By Gender
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Breast Cancer Screening Market
7.4.10.1. Market Size and Forecast, By Test Type
7.4.10.2. Market Size and Forecast, By Gender
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Breast Cancer Screening Market
7.4.11.1. Market Size and Forecast, By Test Type
7.4.11.2. Market Size and Forecast, By Gender
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Test Type
7.5.3. Market Size and Forecast, By Gender
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Breast Cancer Screening Market
7.5.6.1. Market Size and Forecast, By Test Type
7.5.6.2. Market Size and Forecast, By Gender
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Breast Cancer Screening Market
7.5.7.1. Market Size and Forecast, By Test Type
7.5.7.2. Market Size and Forecast, By Gender
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Breast Cancer Screening Market
7.5.8.1. Market Size and Forecast, By Test Type
7.5.8.2. Market Size and Forecast, By Gender
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Breast Cancer Screening Market
7.5.9.1. Market Size and Forecast, By Test Type
7.5.9.2. Market Size and Forecast, By Gender
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Siemens Healthineers AG
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Myriad Genetics, Inc.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Metabolomic Technologies Inc
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Biocrates Lifesciences AG
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. A&G Pharmaceutical
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Provista Diagnostics Inc
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. F. Hoffmann-La Roche AG
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Volpara Health Limited
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Quest Diagnostics Inc.
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. GE Healthcare
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
List of Tables
Table 1. Global Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 2. Bone Wax Market for Absorbable Bone Wax, by Region, 2024 - 2033 ($Million)
Table 3. Bone Wax Market for Non-Absorbable Bone Wax, by Region, 2024 - 2033 ($Million)
Table 4. Global Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 5. Bone Wax Market for Orthopedic Surgery, by Region, 2024 - 2033 ($Million)
Table 6. Bone Wax Market for Thoracic Surgery, by Region, 2024 - 2033 ($Million)
Table 7. Bone Wax Market for Neurosurgery, by Region, 2024 - 2033 ($Million)
Table 8. Bone Wax Market for Others, by Region, 2024 - 2033 ($Million)
Table 9. Global Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 10. Bone Wax Market for Specialty Clinics, by Region, 2024 - 2033 ($Million)
Table 11. Bone Wax Market for Hospitals, by Region, 2024 - 2033 ($Million)
Table 12. Bone Wax Market for Ambulatory Surgery Centers, by Region, 2024 - 2033 ($Million)
Table 13. Bone Wax Market, by Region, 2024 - 2033 ($Million)
Table 14. North America Bone Wax Market, by Country, 2024 - 2033 ($Million)
Table 15. North America Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 16. North America Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 17. North America Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 18. U.S. Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 19. U.S. Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 20. U.S. Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 21. Canada Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 22. Canada Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 23. Canada Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 24. Mexico Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 25. Mexico Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 26. Mexico Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 27. Europe Bone Wax Market, by Country, 2024 - 2033 ($Million)
Table 28. Europe Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 29. Europe Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 30. Europe Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 31. Germany Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 32. Germany Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 33. Germany Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 34. France Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 35. France Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 36. France Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 37. UK Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 38. UK Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 39. UK Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 40. Italy Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 41. Italy Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 42. Italy Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 43. Spain Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 44. Spain Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 45. Spain Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 46. Rest of Europe Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 47. Rest of Europe Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 48. Rest of Europe Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 49. Asia-Pacific Bone Wax Market, by Country, 2024 - 2033 ($Million)
Table 50. Asia-Pacific Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 51. Asia-Pacific Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 52. Asia-Pacific Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 53. Japan Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 54. Japan Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 55. Japan Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 56. China Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 57. China Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 58. China Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 59. Australia Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 60. Australia Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 61. Australia Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 62. India Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 63. India Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 64. India Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 65. South Korea Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 66. South Korea Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 67. South Korea Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 68. Rest of Asia-Pacific Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 69. Rest of Asia-Pacific Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 70. Rest of Asia-Pacific Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 71. LAMEA Bone Wax Market, by Country, 2024 - 2033 ($Million)
Table 72. LAMEA Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 73. LAMEA Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 74. LAMEA Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 75. Brazil Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 76. Brazil Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 77. Brazil Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 78. Saudi Arabia Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 79. Saudi Arabia Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 80. Saudi Arabia Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 81. South Africa Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 82. South Africa Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 83. South Africa Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 84. Rest of LAMEA Bone Wax Market, by Product, 2024 - 2033 ($Million)
Table 85. Rest of LAMEA Bone Wax Market, by Application, 2024 - 2033 ($Million)
Table 86. Rest of LAMEA Bone Wax Market, by End-user, 2024 - 2033 ($Million)
Table 87. Zimmer Biomet Holdings, Inc.: Key Executives
Table 88. Zimmer Biomet Holdings, Inc.: Company Snapshot
Table 89. Zimmer Biomet Holdings, Inc.: Operating Segments
Table 90. Zimmer Biomet Holdings, Inc.: Product Portfolio
Table 91. Zimmer Biomet Holdings, Inc.: Key Strategic Moves and Developments
Table 92. Medline Industries, Inc.: Key Executives
Table 93. Medline Industries, Inc.: Company Snapshot
Table 94. Medline Industries, Inc.: Operating Segments
Table 95. Medline Industries, Inc.: Product Portfolio
Table 96. Medline Industries, Inc.: Key Strategic Moves and Developments
Table 97. Medtronic PLC: Key Executives
Table 98. Medtronic PLC: Company Snapshot
Table 99. Medtronic PLC: Operating Segments
Table 100. Medtronic PLC: Product Portfolio
Table 101. Medtronic PLC: Key Strategic Moves and Developments
Table 102. B Braun Melsungen AG: Key Executives
Table 103. B Braun Melsungen AG: Company Snapshot
Table 104. B Braun Melsungen AG: Operating Segments
Table 105. B Braun Melsungen AG: Product Portfolio
Table 106. B Braun Melsungen AG: Key Strategic Moves and Developments
Table 107. Baxter International, Inc.: Key Executives
Table 108. Baxter International, Inc.: Company Snapshot
Table 109. Baxter International, Inc.: Operating Segments
Table 110. Baxter International, Inc.: Product Portfolio
Table 111. Baxter International, Inc.: Key Strategic Moves and Developments
Table 112. Johnson and Johnson: Key Executives
Table 113. Johnson and Johnson: Company Snapshot
Table 114. Johnson and Johnson: Operating Segments
Table 115. Johnson and Johnson: Product Portfolio
Table 116. Johnson and Johnson: Key Strategic Moves and Developments
Table 117. Dolphin Sutures: Key Executives
Table 118. Dolphin Sutures: Company Snapshot
Table 119. Dolphin Sutures: Operating Segments
Table 120. Dolphin Sutures: Product Portfolio
Table 121. Dolphin Sutures: Key Strategic Moves and Developments
Table 122. Smi AG: Key Executives
Table 123. Smi AG: Company Snapshot
Table 124. Smi AG: Operating Segments
Table 125. Smi AG: Product Portfolio
Table 126. Smi AG: Key Strategic Moves and Developments
Table 127. Orion Sutures India Pvt. Ltd.: Key Executives
Table 128. Orion Sutures India Pvt. Ltd.: Company Snapshot
Table 129. Orion Sutures India Pvt. Ltd.: Operating Segments
Table 130. Orion Sutures India Pvt. Ltd.: Product Portfolio
Table 131. Orion Sutures India Pvt. Ltd.: Key Strategic Moves and Developments
Table 132. Universal Suture: Key Executives
Table 133. Universal Suture: Company Snapshot
Table 134. Universal Suture: Operating Segments
Table 135. Universal Suture: Product Portfolio
Table 136. Universal Suture: Key Strategic Moves and Developments
List of Figures
Figure 1. Global Bone Wax Market, 2024 - 2033
Figure 2. Segmentation of Bone Wax Market, 2024 - 2033
Figure 3. Top Investment Pocket in Bone Wax Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalbone Wax Market
Figure 10. Global Bone Wax Market Segmentation, by Product
Figure 11. Bone Wax Market for Absorbable Bone Wax, by Country, 2024 - 2033 ($Million)
Figure 12. Bone Wax Market for Non-Absorbable Bone Wax, by Country, 2024 - 2033 ($Million)
Figure 13. Global Bone Wax Market Segmentation, by Application
Figure 14. Bone Wax Market for Orthopedic Surgery, by Country, 2024 - 2033 ($Million)
Figure 15. Bone Wax Market for Thoracic Surgery, by Country, 2024 - 2033 ($Million)
Figure 16. Bone Wax Market for Neurosurgery, by Country, 2024 - 2033 ($Million)
Figure 17. Bone Wax Market for Others, by Country, 2024 - 2033 ($Million)
Figure 18. Global Bone Wax Market Segmentation, by End-user
Figure 19. Bone Wax Market for Specialty Clinics, by Country, 2024 - 2033 ($Million)
Figure 20. Bone Wax Market for Hospitals, by Country, 2024 - 2033 ($Million)
Figure 21. Bone Wax Market for Ambulatory Surgery Centers, by Country, 2024 - 2033 ($Million)
Figure 22. Top Winning Strategies, by Year, 2021-2023*
Figure 23. Top Winning Strategies, by Development, 2021-2023*
Figure 24. Top Winning Strategies, by Company, 2021-2023*
Figure 25. Product Mapping of Top 10 Players
Figure 26. Competitive Dashboard
Figure 27. Competitive Heatmap: Bone Wax Market
Figure 28. Top Player Positioning, 2023
Figure 29. Zimmer Biomet Holdings, Inc.: Net Sales, 2021-2023 ($Million)
Figure 30. Zimmer Biomet Holdings, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 31. Zimmer Biomet Holdings, Inc.: Revenue Share, by Region, 2023 (%)
Figure 32. Medline Industries, Inc.: Net Sales, 2021-2023 ($Million)
Figure 33. Medline Industries, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 34. Medline Industries, Inc.: Revenue Share, by Region, 2023 (%)
Figure 35. Medtronic PLC: Net Sales, 2021-2023 ($Million)
Figure 36. Medtronic PLC: Revenue Share, by Segment, 2023 (%)
Figure 37. Medtronic PLC: Revenue Share, by Region, 2023 (%)
Figure 38. B Braun Melsungen AG: Net Sales, 2021-2023 ($Million)
Figure 39. B Braun Melsungen AG: Revenue Share, by Segment, 2023 (%)
Figure 40. B Braun Melsungen AG: Revenue Share, by Region, 2023 (%)
Figure 41. Baxter International, Inc.: Net Sales, 2021-2023 ($Million)
Figure 42. Baxter International, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 43. Baxter International, Inc.: Revenue Share, by Region, 2023 (%)
Figure 44. Johnson and Johnson: Net Sales, 2021-2023 ($Million)
Figure 45. Johnson and Johnson: Revenue Share, by Segment, 2023 (%)
Figure 46. Johnson and Johnson: Revenue Share, by Region, 2023 (%)
Figure 47. Dolphin Sutures: Net Sales, 2021-2023 ($Million)
Figure 48. Dolphin Sutures: Revenue Share, by Segment, 2023 (%)
Figure 49. Dolphin Sutures: Revenue Share, by Region, 2023 (%)
Figure 50. Smi AG: Net Sales, 2021-2023 ($Million)
Figure 51. Smi AG: Revenue Share, by Segment, 2023 (%)
Figure 52. Smi AG: Revenue Share, by Region, 2023 (%)
Figure 53. Orion Sutures India Pvt. Ltd.: Net Sales, 2021-2023 ($Million)
Figure 54. Orion Sutures India Pvt. Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 55. Orion Sutures India Pvt. Ltd.: Revenue Share, by Region, 2023 (%)
Figure 56. Universal Suture: Net Sales, 2021-2023 ($Million)
Figure 57. Universal Suture: Revenue Share, by Segment, 2023 (%)
Figure 58. Universal Suture: Revenue Share, by Region, 2023 (%)

Companies Mentioned

  • Zimmer Biomet Holdings, Inc.
  • Medline Industries, Inc.
  • Medtronic plc
  • B Braun Melsungen AG
  • Baxter International, Inc
  • Johnson & Johnson
  • Dolphin Sutures
  • SMI AG
  • Orion Sutures India Pvt. Ltd
  • Universal Suture

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information